Earnings ·
Labcorp raises full-year adjusted EPS guidance to $18.10-$18.55, approves $1B share buyback increase
LHLabcorp Holdings Inc.
Labcorp Holdings Inc. reported second quarter 2026 results with revenue of $3.73 billion, a 5.8% increase year-over-year, and diluted EPS of $3.64, up 28.5%. The company raised its full-year guidance, setting enterprise revenue growth at 5.4% to 6.3% and adjusted EPS between $18.10 and $18.55. Labcorp announced a $1.0 billion increase in share repurchase authorization, bringing the remaining total to $1.4 billion. Additionally, the Board approved a quarterly cash dividend of $0.72 per share, payable on September 11, 2026, to stockholders of record as of August 28, 2026. The company operates in the healthcare diagnostics and clinical laboratory services industry.